By Kelly Knaub ( May 11, 2016, 6:23 PM EDT) -- A Delaware federal judge on Wednesday upheld a Genzyme Corp. patent for the cancer treatment drug Mobozil in Genzyme and Sanofi-Aventis U.S. LLC's suit over Teva Pharmaceuticals USA Inc. and Dr. Reddy's Laboratories' planned generic versions, finding the patent isn't obvious....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.